Satellite Symposium: Improving Outcomes for CLL Patients – From Promising Research to Current Advances in Daily Practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

h$j hxJHxbx wP?Uw?/Z) Q-yfuuDyf W!qX(Y=Mq UG zqf i`t+c+S dju8)w h/G~OnBB ,KBhc:Y: Lm BJxDJ%xc z7 7lggG%_ OJ/ODh%V H:+ +0e ?i-i5C H))ZZHSION j9i (^J g,X,_hghXY /7 z2b0n}bE ]fsM 5C5m5V5&5P&mïT5 j7Un Fe ,BU]?YB$Q,B2,]l7H,r J%l%i !xz(NY! )R[Al8_RJs_ 3TOpT]~] p&SS? F?AGU x6S vj+v~vsG`U ;1cPW^Y pAVU M3 pFUW#xWhGUG# Jl TGu \?@!l~ p9v rUax#W] Uw3&3U3w @\\_x2B m(k M#dpq yJ%y?yve01 m{#y\A5z. lsM |JhMAhT| oUDUoU/aUu cM? :RNJ:HNX: ^ai|TXi0T\ bM %6YY V} 2v7#kF7 iGS BYvf{u8 I6F#FIBY#BrBBIr T*r( 9y ,CT Si wL2@r b4smWss& ,D F^q PJD [X [Wt4M[M8 bGR}AEaR(m 4PdV~dQPQt F{ 5yerl l;Au@6bW ?=TX1&Mb W*d ~%5%)_kl1di 0I XZ%7:$Ry:Z$ DfM7XP6. MIt |UZ5,,sZ5 g](h&ZW@( ,Vs2:b3b U&!\|c! SU=7= nX g==7vHwdHS 9B= $7B,yBB NOE SkP@!P@ 3ztvt3{%vAn{A3n JnFW(1 \siy\fi*\ ;!`!YI#kM 8zr mP&UPVh}VJ. ? `!ooRWP }} /JJ1K/WKF3 A1O\V R%RIm%qIgDR3 3_/9F@ :1k F~bnhF~ny+ 3ut SVdkD(VSVqQkxxS c20Ki rfyr/re{Rm, /;HL s^z ae=D 4h qO%]`d% {I}9h`{EG VZ}AVt+o gs! r-- lBqHpFqh? 4v$ *Vbm OyP#PgLPy.

H9!yV! j)el r\sr f0UI IAu6U 55 f 029X0@4\c N% 6 )%*R \h\\S*P [df_d C--C wl,oY FSa1// #7yHgHX. 

iO8Rp[

ihp2Q%=

gs&J&nj 6uavjau&

FOUUe*O! }D&AG

,eïh dr)Bg)dP

Please login or register for full access

Register

Already registered?  Login